biosimilars

Samsung Bioepis first to secure EMA backing for Herceptin biosimilar
BioPharma Dive
Mon, 09/18/17 - 09:23 am
Samsung Bioepis
EMA
Europe
biosimilars
Herceptin
Roche
breast cancer
Industry Pulse: 10 charts on M&A, I/O and biosimilar threats
BioPharma Dive
Sun, 09/17/17 - 09:54 am
M&A
immuno-oncology
biosimilars
FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin
Endpoints
Fri, 09/15/17 - 09:14 am
FDA
Scott Gottlieb
Amgen
Allergan
biosimilars
Mvasi
Roche
Avastin
Interchangeable Biosimilars vs. Biosimilars: Experts Explain Guidance, Discuss Development and Uptake
RAPS.org
Wed, 09/13/17 - 10:02 pm
FDA
biosimilars
FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar
RAPS.org
Fri, 09/8/17 - 09:28 am
FDA
Celltrion
biosimilars
Pfizer
Inflectra
Remicade
WHO to Launch Pilot to Prequalify Biosimilars
RAPS.org
Tue, 09/5/17 - 06:59 pm
WHO
biosimilars
cancer
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
Fresenius closes Merck biosimilar biz purchase
Drug Delivery Business News
Fri, 09/1/17 - 11:08 am
Fresenius
Merck KGaA
biosimilars
M&A
Is the System Rigged Against Biosimilars?
Motley Fool
Sat, 08/26/17 - 12:39 pm
biosimilars
Amgen
Amjevita
Biogen, Samsung Humira copy wins EU approval
Fierce Pharma
Fri, 08/25/17 - 09:52 am
Biogen
Samsung Bioepis
Europe
Humira
AbbVie
Imraldi
biosimilars
Remicade Is a Litmus Test for PBMs
Bloomberg
Fri, 08/18/17 - 12:04 am
Remicade
PBMs
biosimilars
CVS Health
Express Scripts
Amgen falls short in Epogen patent appeal but Pfizer stumble delays competition
Fierce Pharma
Fri, 08/11/17 - 11:22 am
Amgen
Epogen
patents
Pfizer
anemia
biosimilars
As Roche wades biosimilar waters, more competitors circle Herceptin
BioPharma Dive
Wed, 08/2/17 - 09:28 pm
Roche
Herceptin
biosimilars
Amgen
Allergan
ABP 980
Celltrion
CT-P6
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
Fierce Pharma
Mon, 07/31/17 - 09:56 pm
FDA
Herceptin
biosimilars
Roche
Amgen
Teva Pharmaceutical
Allergan
Celltrion
Court Ruling on 'Biosimilars' Sets Stage for More Drug Acquisitions
TheStreet.com
Sun, 07/30/17 - 09:44 am
biosimilars
M&A
R&D
Supreme Court
With $39B in cash and biosim threats looming, could Amgen use a deal? Executives say not yet
Fierce Pharma
Wed, 07/26/17 - 10:36 pm
Amgen
biosimilars
M&A
Merck undercuts Pfizer on Remicade biosimilar price
BioPharma Dive
Wed, 07/26/17 - 10:18 pm
Merck
Pfizer
Remicade
drug pricing
biosimilars
Renflexis
JNJ
Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta
Endpoints
Mon, 07/24/17 - 10:40 am
Samsung Bioepis
Remicade
FDA
biosimilars
JNJ
GSK
Benlysta
lupus
Despite scoring an FDA nod, Merck's biosim Lusduna must wait to challenge Lantus
Fierce Pharma
Sun, 07/23/17 - 11:40 am
FDA
Merck
biosimilars
Lusduna Nexvue
Lantus
diabetes
Sanofi
Hatch Waxman Act
How did Johnson & Johnson beat back Remicade's biosim? Call it the art of the deal
Fierce Pharma
Thu, 07/20/17 - 11:18 am
JNJ
Remicade
biosimilars
Pfizer
Inflectra

Pages